Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model
Kim Anthony-Gonda(Lentigen Technology (United States)), Ariola Bardhi(Albert Einstein College of Medicine), Alex Ray(Albert Einstein College of Medicine), Nina C. Flerin(Albert Einstein College of Medicine), Mengyan Li(Albert Einstein College of Medicine), Weizao Chen(National Institutes of Health), Christina Ochsenbauer(University of Alabama at Birmingham), John C. Kappes(University of Alabama at Birmingham), Winfried Krueger(Lentigen Technology (United States)), Andrew Worden(Lentigen Technology (United States)), Dina Schneider(Lentigen Technology (United States)), Zhongyu Zhu(Lentigen Technology (United States)), Rimas J. Orentas(Lentigen Technology (United States)), Dimiter S. Dimitrov(University of Pittsburgh), Harris Goldstein(Albert Einstein College of Medicine), Boro Dropulić(Lentigen Technology (United States))
Cited by 160Open Access
Abstract
T cells during HIV infection using a humanized NSG mouse model of intrasplenic HIV infection. These data suggest that multispecific anti-HIV duoCAR-T cells could be an effective approach for the treatment of patients with HIV-1 infection.
Related Papers
No related papers found
Powered by citation graph analysis